Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for INBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 5.511M
March 31, 2026 8.962M
December 31, 2025 11.09M
September 30, 2025 3.621M
June 30, 2025 2.996M
March 31, 2025 5.114M
December 31, 2024 4.366M
September 30, 2024 6.105M
June 30, 2024 8.329M
March 31, 2024 11.13M
December 31, 2023 3.280M
September 30, 2023 1.356M
June 30, 2023 3.799M
March 31, 2023 6.026M
December 31, 2022 10.35M
September 30, 2022 5.281M
June 30, 2022 6.625M
Date Value
March 31, 2022 8.773M
December 31, 2021 10.11M
September 30, 2021 13.56M
June 30, 2021 15.06M
March 31, 2021 15.93M
December 31, 2020 18.82M
September 30, 2020 -3.015M
June 30, 2020 -5.186M
March 31, 2020 -5.863M
December 31, 2019
September 30, 2019
June 30, 2019 -4.615M
March 31, 2019 -5.202M
December 31, 2018 -4.376M
September 30, 2018
June 30, 2018 -4.376M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Sanara MedTech, Inc. 7.944M
Anteris Technologies Global Corp. 251.39M
20/20 Biolabs, Inc. 3.159M
Quest Diagnostics, Inc. 7.516B
Labcorp Holdings, Inc. 8.607B

Shareholders Equity (Quarterly) Related Metrics